sumatriptan

7.4 Selective Serotonin Reuptake Inhibitors /Serotonin Norepinephrine Reuptake Inhibitors and Serotonin Syndrome Cases of serotonin syndrome have been reported during coadministration of triptans and SSRIs, SNRIs, TCAs, and MAO inhibitors [see Warnings and Precautions (5.7)].

Mechanism: Both drugs can increase serotonin levels in the body, which may lead to a serious reaction called serotonin syndrome.

What to do: Tell your doctor immediately if you experience symptoms like a fast heartbeat, sweating, or muscle stiffness.

Sumatriptan Clinical Impact: There have been postmarketing reports describing patients with weakness, hyperreflexia, and incoordination following the use of an SSRI and sumatriptan. Intervention: If concomitant treatment with sumatriptan and an SSRI is clinically warranted, appropriate observation of the patient is advised [ see Warnings and Precautions (5.2) ].

Mechanism: Combining these medicines can lead to physical issues like weakness and poor coordination by affecting serotonin in the body.

What to do: If you take both, your doctor should monitor you closely for any signs of muscle or coordination problems.

Sumatriptan: Rare postmarketing reports of weakness, hyperreflexia, and incoordination following use of an SSRI and sumatriptan. Sumatriptan - There have been rare postmarketing reports describing patients with weakness, hyperreflexia, and incoordination following the use of a selective serotonin reuptake inhibitor (SSRI) and sumatriptan. If concomitant treatment with sumatriptan and an SSRI (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) is clinically warranted, appropriate observation of the patient is advised.

Mechanism: Both drugs affect serotonin levels in the brain, which can rarely lead to symptoms like muscle weakness or poor coordination.

What to do: If you must take both, your doctor should watch you closely for any signs of muscle problems or coordination issues.

Sumatriptan –There have been rare postmarketing reports describing patients with weakness, hyperreflexia, and incoordination following the use of a selective serotonin reuptake inhibitor (SSRI) and sumatriptan. If concomitant treatment with sumatriptan and an SSRI (e.g., citalopram, fluoxetine, fluvoxamine, paroxetine, sertraline) is clinically warranted, appropriate observation of the patient is advised.

Mechanism: Combining these drugs can rarely cause a reaction that leads to muscle weakness, overactive reflexes, or loss of coordination.

What to do: Your doctor should monitor you for physical symptoms like weakness or coordination issues if you take these together.